Suppliers and packages for tradename: qelbree
✉ Email this page to a colleague
qelbree
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
---|---|---|---|---|---|---|---|---|---|
Supernus Pharms | QELBREE | viloxazine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 211964 | NDA | Supernus Pharmaceuticals, Inc | 17772-131-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-01) | 2021-04-02 |
Supernus Pharms | QELBREE | viloxazine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 211964 | NDA | Supernus Pharmaceuticals, Inc | 17772-131-07 | 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-07) | 2021-04-02 |
Supernus Pharms | QELBREE | viloxazine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 211964 | NDA | Supernus Pharmaceuticals, Inc | 17772-131-30 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-30) | 2021-04-02 |
Supernus Pharms | QELBREE | viloxazine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 211964 | NDA | Supernus Pharmaceuticals, Inc | 17772-131-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-60) | 2021-04-02 |
Supernus Pharms | QELBREE | viloxazine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 211964 | NDA | Supernus Pharmaceuticals, Inc | 17772-131-90 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-90) | 2021-04-02 |
Supernus Pharms | QELBREE | viloxazine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 211964 | NDA | Supernus Pharmaceuticals, Inc | 17772-132-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-132-01) | 2021-04-02 |
Supernus Pharms | QELBREE | viloxazine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 211964 | NDA | Supernus Pharmaceuticals, Inc | 17772-132-07 | 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-132-07) | 2021-04-02 |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |